Briacell Therapeutics CORP. (BCTXZ) SEC Filings — 2025

Filings

• BriaCell Therapeutics Files 8-K — 8-K · Dec 29, 2025
• BriaCell Launches Unit Offering Amidst Positive Clinical Trial Momentum — S-1 · Dec 23, 2025
• BriaCell's Q1 Loss Widens 42% on Soaring R&D Costs — 10-Q · Dec 11, 2025
• Briacell Therapeutics CORP. 8-K Filing — 8-K · Dec 1, 2025
• BriaCell's Immunotherapy Shows Promise in Metastatic Breast Cancer — 10-K · Oct 16, 2025
• BriaCell Therapeutics Corp. Files 8-K — 8-K · Aug 26, 2025
• BriaCell Therapeutics Corp. Enters Material Definitive Agreement — 8-K · Jul 16, 2025
• BriaCell Amends S-1 for Continuous Offering, Eyes Public Capital — S-1/A · Jul 10, 2025
• BriaCell Amends S-1, Signals Continuous Offering Strategy — S-1/A · Jul 9, 2025
• BriaCell Files S-1 for Continuous Offering, Signaling Capital Raise — S-1 · Jul 8, 2025
• BriaCell Therapeutics Files 8-K Report — 8-K · Jun 18, 2025
• BriaCell's Q3 Loss Widens Amid Increased R&D Spend — 10-Q · Jun 16, 2025
• BriaCell Therapeutics Corp. Signs Material Definitive Agreement — 8-K · Apr 28, 2025
• BriaCell Therapeutics Corp. Files S-1/A Amendment — S-1/A · Apr 23, 2025
• BriaCell Therapeutics Files S-1 for Potential Offering — S-1 · Apr 22, 2025
• BriaCell Therapeutics Files 8-K — 8-K · Mar 12, 2025
• BriaCell to Acquire Inovio Pharmaceuticals for $100M — 8-K · Feb 13, 2025
• BriaCell Therapeutics Holds Security Holder Vote — 8-K · Feb 6, 2025
• BriaCell Therapeutics Corp. Files 8-K — 8-K · Feb 5, 2025
• BriaCell Therapeutics to Acquire Inovio Pharmaceuticals — 8-K · Jan 28, 2025
• BriaCell Therapeutics Corp. Files 8-K — 8-K · Jan 3, 2025